Abbott Laboratories (ABT) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Abbott Laboratories (ABT) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.39 Bn | 18.98 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.76% |
| Mar 31, 2026 | -9.61% |
| Dec 31, 2025 | -3.76% |
| Sep 30, 2025 | 6.04% |
| Jun 30, 2025 | 27.21% |
| Mar 31, 2025 | 18.75% |
| Dec 31, 2024 | 54.63% |
| Sep 30, 2024 | 11.53% |
| Jun 30, 2024 | 5.42% |
| Mar 31, 2024 | 12.89% |
| Dec 31, 2023 | 19.69% |
| Sep 30, 2023 | 20.72% |
| Jun 30, 2023 | 13.50% |
| Mar 31, 2023 | 26.00% |
| Dec 31, 2022 | 26.53% |
| Sep 30, 2022 | 19.01% |
| Jun 30, 2022 | 48.33% |
| Mar 31, 2022 | 42.36% |
| Dec 31, 2021 | 20.09% |
| Sep 30, 2021 | 52.91% |